CVE-2026-17264: RadiAnt DICOM 0 through 2025.2

CVE-2026-17264. CVSS 3.1 base score 4.3 (MEDIUM, Vendor/CNA). EPSS 0.00481 (percentile 0.40503), scored 22-Oct-2026.

Affected technology

RadiAnt DICOM · 0 through 2025.2
Medixant

Component: Not specified by the source

Attack conditions (Vendor/CNA, CVSS 4.0): Network (remote) · No privileges required · Passive user interaction

What an attacker can do

An attacker may remotely execute arbitrary code. Vendor/CNA’s CVSS 4.0 assessment (base score 5.3/10) rates confidentiality and integrity impact as none; availability impact as low.

Published 24-Oct-2026 01:44 UTC

CWE: CWE-787
CCR priority: 17.3 /100 (P5)
CVSS 3.1: 4.3 /10 · CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:L · Vendor/CNA
EPSS: 0.00481 · percentile 0.40503 · 2026-10-22
KEV: no

Provenance

NVD CVE API 2.0 · Source record · observed 2026-10-24 01:40:49.068977+00:00 UTC

Stable permalink: https://cybercodered.org/item/cve-cve-2026-17264.html